Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer

NCT00051688 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: tezacitabine
DRUG: oxaliplatin

Sponsor

Chiron Corporation